For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
PHO survey triggers practices’ low-pulse alarm
PHO survey triggers practices’ low-pulse alarm

We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!
This article was first published on 3 October.
From Martin: As well as reiterating the troubled state of general practice, this story was the beginning of the fees-review-cafe-in-a-practice mini-drama. The idea had popped up in the anonymised PHOs survey but seemed implausible, so I left it to the last paragraph. WellSouth later corroborated it on RNZ, without naming the mystery practice
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.